Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05 04:00PM ET
25.32
Dollar change
-0.88
Percentage change
-3.36
%
IndexRUT P/E- EPS (ttm)-3.20 Insider Own5.88% Shs Outstand69.96M Perf Week-1.17%
Market Cap1.77B Forward P/E- EPS next Y-3.11 Insider Trans-4.34% Shs Float65.87M Perf Month17.66%
Income-198.24M PEG- EPS next Q-0.81 Inst Own98.84% Short Float6.22% Perf Quarter56.49%
Sales85.16M P/S20.81 EPS this Y-77.75% Inst Trans15.04% Short Ratio6.84 Perf Half Y15.56%
Book/sh10.35 P/B2.45 EPS next Y15.88% ROA-22.50% Short Interest4.10M Perf Year35.98%
Cash/sh7.76 P/C3.26 EPS next 5Y- ROE-28.47% 52W Range15.31 - 27.24 Perf YTD19.27%
Dividend Est.- P/FCF60.72 EPS past 5Y-9.81% ROI-24.76% 52W High-7.05% Beta0.70
Dividend TTM- Quick Ratio6.23 Sales past 5Y70.11% Gross Margin85.51% 52W Low65.38% ATR (14)0.91
Dividend Ex-Date- Current Ratio6.23 EPS Y/Y TTM-61.20% Oper. Margin-253.73% RSI (14)60.02 Volatility3.30% 3.55%
Employees280 Debt/Eq0.12 Sales Y/Y TTM-41.37% Profit Margin-232.77% Recom1.36 Target Price32.50
Option/ShortYes / Yes LT Debt/Eq0.11 EPS Q/Q-76.14% Payout- Rel Volume1.56 Prev Close26.20
Sales Surprise-26.61% EPS Surprise27.65% Sales Q/Q-81.90% EarningsNov 06 AMC Avg Volume599.45K Price25.32
SMA203.10% SMA5013.50% SMA20020.17% Trades Volume935,300 Change-3.36%
Date Action Analyst Rating Change Price Target Change
Dec-02-24Upgrade Piper Sandler Neutral → Overweight $20 → $30
Apr-16-24Reiterated BTIG Research Buy $56 → $38
Feb-28-24Downgrade Piper Sandler Overweight → Neutral $37 → $24
May-19-23Initiated BofA Securities Buy $42
Dec-06-22Initiated Cowen Outperform
Oct-13-22Upgrade Raymond James Outperform → Strong Buy $58
Sep-21-22Initiated JP Morgan Overweight $37
Jul-06-22Resumed Canaccord Genuity Buy $50
Feb-11-22Initiated BMO Capital Markets Outperform $54
Jan-21-22Initiated SMBC Nikko Outperform $60
Dec-04-24 09:55AM
Nov-26-24 04:01PM
Nov-18-24 09:55AM
Nov-14-24 09:55AM
Nov-06-24 05:15PM
04:11PM Loading…
04:11PM
04:01PM
Nov-04-24 07:00AM
Nov-01-24 09:55AM
Oct-29-24 10:01AM
Oct-18-24 03:05PM
Oct-16-24 09:55AM
Oct-10-24 08:09AM
Oct-04-24 08:01AM
Sep-12-24 04:01PM
04:55AM Loading…
04:55AM
Sep-11-24 06:31AM
Sep-10-24 04:01PM
Sep-09-24 07:31AM
Sep-06-24 08:01AM
Aug-05-24 09:55PM
05:15PM
04:12PM
04:01PM
Jun-13-24 08:01AM
May-10-24 01:45PM
06:20AM
May-09-24 11:54PM
05:18PM
04:09PM
10:00AM Loading…
May-06-24 10:00AM
May-03-24 07:01PM
May-02-24 03:31AM
Apr-09-24 08:01AM
Mar-08-24 05:01PM
Mar-07-24 05:00PM
Feb-28-24 04:01PM
09:35AM
08:38AM
Feb-27-24 05:20PM
04:39PM
04:26PM
04:01PM
Feb-20-24 04:31PM
Feb-19-24 03:37AM
Feb-15-24 10:00AM
Jan-03-24 04:01PM
09:55AM
Jan-02-24 08:01AM
Dec-30-23 05:02PM
Nov-21-23 04:01PM
Nov-09-23 02:19PM
Nov-08-23 05:21AM
Nov-07-23 04:39PM
04:01PM
04:01PM
Nov-03-23 12:01PM
Oct-31-23 04:01PM
12:00PM
Oct-26-23 08:01AM
Oct-17-23 04:21AM
Sep-27-23 09:01AM
Sep-19-23 04:01PM
Aug-08-23 06:01AM
Aug-07-23 04:02PM
Aug-03-23 05:15PM
04:13PM
04:01PM
Jul-27-23 08:01AM
Jul-03-23 08:38PM
Jun-21-23 08:00PM
Jun-18-23 10:00AM
May-30-23 06:01PM
May-09-23 01:49PM
May-08-23 05:15PM
04:08PM
04:01PM
May-01-23 04:01PM
Apr-26-23 08:00PM
08:01AM
Apr-17-23 01:31PM
Apr-09-23 01:19PM
Mar-14-23 04:31PM
02:56AM
Feb-28-23 05:10AM
Feb-25-23 07:17AM
Feb-23-23 05:25PM
04:01PM
Feb-20-23 10:00AM
Feb-16-23 04:01PM
Feb-07-23 04:01PM
Jan-26-23 02:33PM
Jan-09-23 08:01AM
Jan-05-23 06:30AM
Jan-04-23 04:01PM
Dec-12-22 03:44PM
10:00AM
Nov-30-22 09:55AM
Nov-25-22 12:00PM
Nov-10-22 04:01PM
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Monrovia, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Montgomery Alan BruceDirectorDec 02 '24Option Exercise17.1013,301227,45822,441Dec 04 06:08 PM
Montgomery Alan BruceDirectorDec 04 '24Option Exercise16.761,42123,81210,561Dec 04 06:08 PM
Montgomery Alan BruceDirectorDec 02 '24Sale27.0313,301359,5259,140Dec 04 06:08 PM
Montgomery Alan BruceDirectorDec 04 '24Sale27.031,42138,4069,140Dec 04 06:08 PM
Montgomery Alan BruceDirectorDec 04 '24Proposed Sale27.031,42138,406Dec 04 04:10 PM
Montgomery Alan BruceDirectorDec 02 '24Proposed Sale27.0313,301359,525Dec 02 04:53 PM
Dahiyat Bassil IPRESIDENT & CEONov 21 '24Option Exercise15.6949,278773,172401,893Nov 25 04:04 PM
Dahiyat Bassil IPRESIDENT & CEONov 22 '24Option Exercise15.6913,548212,568366,163Nov 25 04:04 PM
Dahiyat Bassil IPRESIDENT & CEONov 21 '24Sale24.0749,2781,186,363352,615Nov 25 04:04 PM
Dahiyat Bassil IOfficerNov 21 '24Proposed Sale24.0749,2781,186,362Nov 21 04:21 PM
Dahiyat Bassil IPRESIDENT & CEONov 13 '24Option Exercise15.693,36652,813355,981Nov 14 06:38 PM
Dahiyat Bassil IPRESIDENT & CEONov 13 '24Sale24.023,36680,842352,615Nov 14 06:38 PM
Desjarlais John RSR. VICE PRESIDENT & CSONov 11 '24Option Exercise15.6968,6841,077,652268,788Nov 13 05:46 PM
Desjarlais John RSR. VICE PRESIDENT & CSONov 12 '24Option Exercise15.6912,774200,424212,878Nov 13 05:46 PM
Desjarlais John RSR. VICE PRESIDENT & CSONov 11 '24Sale23.4868,6841,612,639200,104Nov 13 05:46 PM
Dahiyat Bassil IOfficerNov 13 '24Proposed Sale24.023,36680,842Nov 13 04:21 PM
Desjarlais John ROfficerNov 11 '24Proposed Sale23.4868,6841,612,638Nov 12 08:33 AM
ROSA-BJORKESON DAGMARDirectorSep 27 '24Sale20.682,50351,7628,490Oct 01 04:13 PM
RANIERI RICHARD JDirectorSep 27 '24Sale20.682,50351,7628,490Oct 01 04:12 PM
GUSTAFSON KURT ADirectorSep 27 '24Sale20.682,50351,7629,490Oct 01 04:10 PM
GORMAN KEVIN CHARLESDirectorSep 27 '24Sale20.682,65454,8858,392Oct 01 04:09 PM
Montgomery Alan BruceDirectorSep 27 '24Sale20.681,85338,3209,140Oct 01 04:08 PM
Feigal EllenDirectorSep 27 '24Sale20.682,50351,7628,490Oct 01 04:07 PM
GORMAN KEVIN CHARLESDirectorSep 27 '24Proposed Sale20.682,65454,885Sep 27 10:58 AM
Montgomery Alan BruceDirectorSep 27 '24Proposed Sale20.681,85338,320Sep 27 10:39 AM
Feigal EllenDirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 10:35 AM
RANIERI RICHARD JDirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 10:29 AM
GUSTAFSON KURT ADirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 10:12 AM
ROSA-BJORKESON DAGMARDirectorSep 27 '24Proposed Sale20.682,50351,762Sep 27 09:41 AM
Desjarlais John RSR. VICE PRESIDENT & CSOJul 09 '24Option Exercise10.7342,215452,967228,648Jul 11 06:41 PM
Desjarlais John RSR. VICE PRESIDENT & CSOJul 10 '24Option Exercise10.737,78583,533200,104Jul 11 06:41 PM
Desjarlais John RSR. VICE PRESIDENT & CSOJul 09 '24Sale18.3236,329665,511192,319Jul 11 06:41 PM
Valente NancyEVP, Chief Development OfficerMay 02 '24Sale23.584,745111,87255,115May 03 04:06 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 11 '24Sale23.5084919,953121,070Mar 12 04:08 PM
Eckert CeliaSVP, GENERAL COUNSELMar 11 '24Sale23.5085019,97745,465Mar 12 04:06 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 11 '24Sale23.501,28030,082186,433Mar 12 04:05 PM
Dahiyat Bassil IPRESIDENT & CEOMar 11 '24Sale23.502,74164,418351,894Mar 12 04:03 PM
GUSTAFSON KURT ADirectorMar 06 '24Option Exercise10.7315,000160,95020,007Mar 07 04:10 PM
GUSTAFSON KURT ADirectorMar 06 '24Sale23.1814,000324,4536,007Mar 07 04:10 PM
Kuch John JSR. VICE PRESIDENT & CFOMar 05 '24Sale23.434,474104,821121,919Mar 07 04:07 PM
Desjarlais John RSR. VICE PRESIDENT & CSOMar 05 '24Sale23.436,629155,311166,989Mar 07 04:05 PM
Eckert CeliaSVP, GENERAL COUNSELMar 05 '24Sale23.433,89291,18633,226Mar 07 04:03 PM
Dahiyat Bassil IPRESIDENT & CEOMar 05 '24Sale23.4312,528293,519300,097Mar 07 04:01 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 14 '24Option Exercise11.0511,943131,970173,618Feb 16 04:06 PM
GORMAN KEVIN CHARLESDirectorFeb 13 '24Buy19.12531,0135,060Feb 15 04:02 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 13 '24Option Exercise11.0568,057752,030215,783Feb 14 02:23 PM
Desjarlais John RSR. VICE PRESIDENT & CSOFeb 13 '24Sale19.3854,1081,048,743161,675Feb 14 02:23 PM
Dahiyat Bassil IPRESIDENT & CEODec 29 '23Option Exercise11.0565,001718,261357,929Dec 29 04:24 PM
Dahiyat Bassil IPRESIDENT & CEODec 29 '23Sale20.9345,000941,670312,929Dec 29 04:24 PM